<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1911246256
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PREDO 15MG-5ML SYRUP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PREDNISOLONE SODIUM PHOSPHATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Syrup
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        120
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        42
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jazeera Pharmaceutical Industries (JPI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01BA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><ul><li>Prednisolone is a steroid medicine, prescribed for many different conditions, including serious illnesses.</li><li>You need to take it regularly to get the maximum benefit.</li><li>Do not stop taking this medicine without talking to your doctor. You may need to reduce the dose gradually.</li><li>Prednisolone can cause side effects in some people (read section 4 below). Some side effects such as mood changes (feeling depressed or &ldquo;high&rdquo;) or stomach problems can happen straight away. If you feel unwell in any way, keep taking your syrup, but see your doctor straight away.</li><li>Some side effects only happen after weeks or months.</li></ul><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;These include weakness of arms and legs or developing a rounder face (read section 4 for more information).</p><ul><li>Keep away from people who have chicken‐pox or shingles, if you have never had them. They could affect you severely. If you do come into contact with&nbsp; &nbsp;chickenpox or shingles, see your doctor straight away.</li></ul><p><strong>&nbsp;What Predo is and what it is used for</strong></p><p>This&nbsp;medicine contains the active &nbsp;ingredient prednisolone, &nbsp;which &nbsp;belongs to &nbsp;a group of medicines called &nbsp;corticosteroids&nbsp;or&nbsp;&ldquo;steroids&rdquo;. &nbsp;Steroids &nbsp;work &nbsp;by reducing&nbsp;<br />inflammation and lowering the body&rsquo;s immune response.</p><p>Predo is used to treat a variety of inflammatory diseases including &nbsp;severe &nbsp;asthma, &nbsp;rheumatoid&nbsp; &nbsp;arthritis, &nbsp;allergic reactions, &nbsp;severe&nbsp; skin conditions, &nbsp; and &nbsp; some &nbsp; blood disorders.<br /><strong>Predo &ndash; benefit information</strong><br />Predo &nbsp;belongs &nbsp;to &nbsp;a &nbsp;group &nbsp;of &nbsp;medicines &nbsp;called &nbsp;steroids. Their full name is corticosteroids.&nbsp; These corticosteroids occur naturally in the body and help to maintain health and &nbsp; &nbsp;well‐being. Boosting your body with extra corticosteroids (such as prednisolone) is an effective&nbsp; way to &nbsp;treat &nbsp;various illnesses&nbsp;involving&nbsp;inflammation &nbsp;in &nbsp;the body. &nbsp;Predo reduces &nbsp;this &nbsp;inflammation, &nbsp;which &nbsp;could otherwise go on making your condition worse. You must take &nbsp;this&nbsp; &nbsp;medicine &nbsp;regularly &nbsp;to &nbsp;get &nbsp;maximum &nbsp;benefit from it.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Predo:</strong></p><ul><li>If you are allergic to prednisolone or any of the other ingredients of this medicine (listed in section 6). Allergic reactions include mild symptoms such as itching and/or rash. More severe symptoms include swelling of the face, lips, tongue and/or throat with difficulty in swallowing or breathing;</li><li>If you have recently had a vaccination or have a vaccination planned.</li><li>If you have a viral infection such as measles, chickenpox or shingles or any other infection. Tell your doctor immediately if you have come into contact with anyone suffering with measles, chickenpox or shingles in the last three months.</li><li>If you have a tropical worm infections</li><li>If you have systemic fungal infections</li></ul><p><strong>Warnings and Precautions</strong></p><p>Talk to your doctor of pharmacist before taking Predo, especially if you have, have ever had or if anyone in your family has suffered from:</p><ul><li>Severe depression or manic‐depressive illness (bipolar disorder). This includes having had depression before or while taking steroid medicines like Predo.</li><li>TB (tuberculosis);</li><li>Diabetes;</li><li>Epilepsy;</li><li>Depression or other mental illness;</li><li>An eye disease caused by a rise of pressure within the eye (glaucoma);</li><li>Thinning of the bones (osteoporosis);</li><li>Muscle problems when steroids were taken before;</li><li>Stomach ulcers;</li><li>Renal failure, high blood pressure, heart failure or recently suffered a heart attack;</li><li>Scleroderma (also known as systemic sclerosis, an autoimmune disorder) because daily doses of 15 mg or more may increase the risk of a serious complication called scleroderma renal crisis. Signs of scleroderma renal crisis include increased blood pressure and decreased urine production. The doctor may advise that you have your blood pressure and urine regularly checked;</li><li>Any liver problem;</li><li>An under‐active thyroid (hypothyroidism).</li></ul><p>If any of the above applies to you, or if you are not sure, talk to your doctor or pharmacist before you use this medicine.</p><p><strong>Mental health problems while taking prednisolone </strong></p><p>Mental health problems can occur while taking steroids like prednisolone (see also section 4, &ldquo;Possible side effects&rdquo;).</p><ul><li>These illnesses can be severe.</li><li>Usually they start within a few days or weeks of starting the medicine.</li><li>They are more likely to happen at high doses.</li><li>Most of these problems go away if the dose is lowered or the medicine is stopped. However, if problems do occur, they might need treatment.</li></ul><p>Talk to a doctor if you (or someone taking this medicine) show any signs of mental health problems. This is particularly important if you are depressed or might be thinking about suicide. In a few cases, mental health problems have also happened when the doses have been lowered or the medicine stopped altogether.</p><p>Talk to a doctor if blurred vision, difficulty in reading or any other change in vision occurs during or after treatment.</p><p>Regular checkups with doctors (including vision checkups in three month‐intervals) are advised during long term treatment.</p><p><strong>Other medicines and Predo</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is especially important if you are taking:</p><ul><li>Medicines for epilepsy such as carbamazepine, phenobarbitone, phenytoin or primidone;</li><li>Antibiotics such as rifampicin, erythromycin;</li><li>Mifepristone (used to terminate pregnancy);</li><li>Ritonavir (used in HIV treatment);</li><li>Oral contraceptives;</li><li>Somatropin (used to treat growth problems);</li><li>Medicines for diabetes such as insulin, glibenclamide or metformin;</li><li>Medicines used to treat high blood pressure, such as diuretics (water tablets) like bendroflumethiazide and furosemide;</li><li>Warfarin or other medicines used to thin the blood;</li><li>Aspirin or similar medicines;</li><li>Theophylline (used to treat asthma);</li><li>Medicines to treat fungal infections such as amphotericin, ketoconazole;</li><li>Acetazolamide (used to treat glaucoma);</li><li>Carbenoxolone (used to treat stomach ulcers);</li><li>Methotrexate (used for rheumatoid arthritis, psoriasis and certain types of cancer);</li><li>Any medicine which belongs to a group of medicines called sympathomimetics;</li><li>Medicines used to treat myasthenia gravis;</li><li>Medicines used to make x‐rays clearer;</li><li>Ciclosporin (used to stop the body rejecting bone marrow or organ transplants).</li></ul><p>Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>Some medicines may increase the effects of Predo and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).</p><p><strong>Pregnancy, breast‐feeding and fertility</strong></p><p>If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><em>Pregnancy</em></p><p>During pregnancy treatment should only be initiated after a careful benefit/risk assessment has been performed. Because growth retardation and damage to the unborn child cannot be excluded upon prolonged treatment with glucocorticoids during pregnancy, please inform your doctor if you want to become pregnant, are already pregnant or if you are assuming that you are pregnant.</p><p><em>Breastfeeding</em></p><p>Glucocorticoids, such as prednisolone pass into breast milk. Damage to the infant is not reported to date. Nevertheless, when high doses of prednisolone are given you should avoid breast‐feeding for 4 h after a dose. Please consult your doctor.</p><p><em>Fertility</em></p><p>After high prednisolone doses (30 mg/day for at least 4 weeks) reversible disturbances of spermatogenesis has been observed, which lasted for several months after stop taking the medicine.</p><p><strong>Driving and using machines</strong></p><p>This medicine should not affect your ability to drive or use machines.</p><p><strong>Predo contains methyl p‐hydroxybenzoate (methyl paraben), propylene glycol and sugar</strong></p><p><em>Predo contains methyl p‐hydroxybenzoate (methyl paraben)</em></p><ul><li>May cause allergic reactions (possibly delayed).</li></ul><p><em>Predo contains propylene glycol</em></p><ul><li>If your child is less than 5 years old, talk to your doctor or pharmacist before giving them this medicine, in particular if they use other medicines that contain propylene glycol or alcohol.</li></ul><p><em>Predo contains sugar</em></p><ul><li>This should be taken into account in patients with diabetes mellitus. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><ul><li>It is best to take the syrup undiluted.</li><li>The syrup should be taken by mouth.</li><li>The syrup should preferably be taken as a single dose in the morning. However, divided daily dosage may be employed if required</li><li>In children, the medicine should preferably be taken as a single dose on alternate days.</li><li>Shake well before use.</li><li>If you are on long‐term therapy, make sure your supply of syrup does not run out.</li><li>The dosage depends on the condition being treated and, for an adult, can vary widely between 10 mg and 30 mg daily in divided doses. Your doctor will give you the smallest dose that works for your condition.</li><li>The package contains a measuring oral syringe dosing 5 ml.</li></ul><p><strong>Use in children</strong></p><p>To treat acute asthma attacks, your child&rsquo;s doctor may prescribe:</p><ul><li>For children younger than 2 years old, 10 mg daily, for up to three days;</li><li>For children 2 to 5 years old, 20 mg daily. Treatment for up to three days is usually sufficient, but the length of the course will be decided by your doctor, according to the number of days necessary to recover.</li><li>For children older than 5 years old, 30 mg daily or more (up to 40 mg daily). In case more than 30 mg daily have been prescribed, ask your child&rsquo;s doctor, as a different prednisolone presentation might be more appropriate.</li></ul><p>If you have the impression that the effect of this medicine is too strong or too weak, talk to your doctor or pharmacist.</p><p><strong>If you take more Predo than you should</strong></p><p>If you take more Predo than prescribed, contact your doctor or nearest hospital emergency department immediately. Take this leaflet and/or the package with you to show the doctor what you have taken.</p><p><strong>If you forget to take Predo</strong></p><p>If you forget to take Predo, take the next dose as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking Predo</strong></p><p>Talk to your doctor if you want to stop taking the syrup &ndash; your doctor may want to reduce your dose gradually.</p><p>Do not stop taking the syrup unless you have been told to do so by your doctor, even if you feel better, as it can make you ill. If you stop taking the syrup suddenly, this can cause withdrawal symptoms such as fever, sickness, pain in the muscles and joints, runny nose, sore, red and sticky eyes (conjunctivitis), itchy skin and weight loss.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Steroids including prednisolone can cause severe mental health problems, such as those listed below. These are common in both adults and children. If you notice any of these problems talk to a doctor immediately:</p><ul><li>Feeling depressed, including thinking about suicide.</li><li>Feeling high (mania) or having moods that go up and down.</li><li>Feeling anxious, having problems sleeping, having difficulty in thinking or being confused and losing your memory.</li><li>Feeling, seeing or hearing things which do not exist (hallucinations). Having strange and frightening thoughts, changing how you act or having feelings of being alone.</li></ul><p><strong>The following side effects may be signs of an allergic reaction. If you notice any of the below, stop taking Predo and tell your doctor immediately:</strong></p><ul><li>Itching or skin rashes;</li><li>Swelling of the face, lips or throat;</li><li>Difficulty in breathing or wheeziness.</li></ul><p><strong>The following side effects can occur if steroids are given in high doses for a long time:</strong></p><ul><li>Generally feeling unwell;</li><li>Feeling sick (nausea);</li><li>Hiccups;</li><li>Indigestion or stomach discomfort;</li><li>Stomach ulcer (which can rupture and bleed) or ulcer in the oesophagus (gullet);</li><li>Thrush;</li><li>Inflammation of the pancreas causing abdominal pain (pancreatitis);</li><li>Muscle weakness;</li><li>Muscle pain;</li><li>Thinning of bones which makes fractures more likely (osteoporosis);</li><li>Damage to tendons;</li><li>&nbsp;Joint stiffness causing limited movement, pain and muscle spasms;</li><li>Fluid retention causing swelling;</li><li>Feeling dehydrated;</li><li>High blood pressure (hypertension);</li><li>Slow healing of wounds, thinning of the skin, bruising, acne, marks which look like stretch marks;</li><li>Small red, purple or blue spots found along the surface of the skin (caused by blood vessels under the skin);</li><li>Low adrenal gland function;</li><li>Slowed growth in infants, children and teenagers;</li><li>Irregular or stopped menstrual periods;</li><li>Swollen round face (Cushingoid facies or moon‐face);</li><li>Excess hair growth;</li><li>Increased appetite and weight gain;</li><li>Intolerance to carbohydrates;</li><li>Mood changes, dependence, depression, difficulty sleeping, worsening of schizophrenia;</li><li>Severe headaches with blurred vision or temporary visual problems in children (usually after stopping treatment);</li><li>Worsening of epilepsy;</li><li>Raised pressure in the eyes (glaucoma), cataracts, thinning and inflammation of the cornea (part of the eye), worsening of viral or fungal eye diseases, blurred vision and visual impairment, choroid and retinal disorders (chorioretinopathy);</li><li>Heart attack (sudden severe chest pains);</li><li>Changes in body chemistry;</li><li>Increase in the number of white blood cells;</li><li>Formation of blood clots;</li><li>Porphyria;</li><li>Steven‐Johnson syndrome;</li><li>Long‐term use of high dose steroids, may lead to a weakening of the immune system, which can increase the risk of your condition getting worse (malignancy).</li></ul><p>Scleroderma renal crisis in patients already suffering from scleroderma (an autoimmune disorder). Signs of scleroderma renal crisis include increased blood pressure and decreased urine production.</p><p>Kaposi&rsquo;s sarcoma (a type of cancer) has also been reported to occur in patients receiving corticosteroids. However, once the treatment has been stopped, this may go away.</p><p>This medicine can make it easier for you to pick up infections which may very rarely be fatal. Infections such as chickenpox and measles can be made worse or TB (tuberculosis) may recur.</p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Store below 30&deg;C.</p><p>Store in the original package.</p><p>The shelf life after first opening is 1 month.</p><p>Do not use this medicine after the expiry date which is stated on the package after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice any visible signs of deterioration.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is prednisolone sodium phosphate.</p><p>Each 1 ml of Predo 15 mg/5 ml Syrup contains prednisolone sodium phosphate equivalent to 3 mg prednisolone.</p><p>The other ingredients are methyl paraben, propylene glycol, glycerin, dibasic sodium phosphate, monobasic sodium phosphate, disodium edeta, saccharine sodium, caramel cream liquid flavor, raspberry liquid flavor, sugar, FD&amp;C Red #40 and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Predo 15 mg/5 ml Syrup is a red clear liquid syrup with raspberry flavour.
Predo 15 mg/5 ml Syrup is available in amber glass bottle sealed with white child resistant cap. The pack also contains 5 ml oral dosing syringe.
Pack size: 1 bottle (120 ml).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong></p><p>Jazeera Pharmaceutical Industries</p><p>Al‐Kharj Road</p><p>P.O. BOX 106229</p><p>Riyadh 11666, Saudi Arabia</p><p>Tel: + (966‐11) 8107023, + (966‐11) 2142472</p><p>Fax: + (966‐11) 2078170</p><p>e‐mail: <u>jpimedical@hikma.com</u></p><p><strong>Manufacturer</strong></p><p>Jazeera Pharmaceutical Industries</p><p>Al‐Kharj Road</p><p>P.O. BOX 106229</p><p>Riyadh 11666, Saudi Arabia</p><p>Tel: + (966‐11) 8107023, + (966‐11) 2142472</p><p>Fax: + (966‐11) 2078170</p><p>e‐mail: <u>jpimedical@hikma.com</u></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 08/2019; version number SA1.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">محتويات العبوة ومعلومات إضافية</p><ul dir="rtl"><li>بريدنيزولون هو دواء ستيرويدي، ويتم وصفه للعديد من الحالات &nbsp;المختلفة، بما فيها الأمراض الخطيرة.</li><li>تحتاج تناوله بانتظام من أجل الحصول على الفائدة القصوى من العلاج.</li><li>لا تتوقف عن تناول هذا الدواء دون التحدث إلى طبيبك. قد تحتاج إلى تقليل الجرعة تدريجياً.</li><li>قد يسبب بريدنيزولون آثاراً جانبية لدى بعض الأشخاص (اقرأ القسم 4 أدناه). بعض الآثار الجانبية مثل التقلبات المزاجية (الشعور بالاكتئاب أو &quot;الابتهاج&quot;) أو مشاكل المعدة قد تحدث على الفور. في حال شعورك بتوعك بأي شكل من الأشكال، تابع تناول الشراب، ولكن عليك زيارة طبيبك على الفور.</li><li>بعض الآثار الجانبية تحدث فقط بعد أسابيع أو شهور. قد تشمل ضعف &nbsp;الذراعين والساقين أو يصبح الوجه مدوّر بشكل أكبر (اقرأ القسم 4لمزيد من المعلومات).</li><li>ابتعد عن الأشخاص المصابين بمرض جدري الماء أو الهربس &nbsp;النطاقي، إذا لم تصب بهما سابقا. حيث قد يؤثرا عليك بشكل خطير. في حال التلامس مع أحد المصابين بمرض جدري الماء أو الهربس النطاقي، عليك زيارة طبيبك على الفور.</li></ul><p dir="RTL"><strong>&nbsp;</strong><strong>ما هو بريدو وما هي دواعي استخدامه</strong></p><p dir="RTL">يحتوي هذا الدواء على المادة الفعّالة بريدنيزولون، والتي تنتمي إلى مجموعة من الأدوية تسمى الستيرويدات القشرية أو &quot;الستيرويدات&quot;. تعمل الستيرويدات على تقليل الالتهابات وخفض الاستجابة المناعية للجسم.</p><p dir="RTL">يستخدم بريدو في علاج العديد من الأمراض الالتهابية بما في ذلك الربو الشديد، التهاب المفاصل الروماتويدي، ردود الفعل التحسسية، الحالات الجلدية الشديدة، وبعض اضطرابات الدم.</p><p dir="RTL"><strong>بريدو &ndash; معلومات مفيدة</strong></p><p dir="RTL">ينتمي بريدو إلى مجموعة من الأدوية تسمى الستيرويدات. اسمها الكامل الستيرويدات القشرية. توجد الستيرويدات القشرية في الجسم بشكل طبيعي وهي تساعد في الحفاظ على الصحة والعافية. يعد تعزيز الجسم بستيرويدات قشرية إضافية (مثل بريدنيزولون) طريقة فعالة لعلاج العديد من الأمراض التي تشمل أي التهابات في الجسم. يقلل بريدو من هذه الالتهابات، التي إذا استمرت قد تسبب تدهور حالتك. يجب عليك تناول هذا الدواء بانتظام من أجل أن تحصل على الفائدة القصوى منه.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><ul dir="rtl"><li>إذا كنت تعاني من حساسية لبريدنيزولون أو لأي من المواد الأخرى المستخدمة في تركيبة هذا الدواء (المذكورة في القسم 6 )تشمل ردود الفعل التحسسية الأعراض البسيطة مثل الحكة و/أو الطفح الجلدي. &nbsp;تشمل الأعراض الأكثر شدة تورم الوجه، الشفتين، اللسان و/أو الحلق مع صعوبة في البلع أو التنفس؛</li><li>إذا تم إعطاؤك مطعوم مؤخر اً أو كنت تخطط لأخذ مطعوم.</li><li>إذا تعرضت لعدوى فيروسية مثل الحصبة، جدري الماء أو الهربس النطاقي أو أي عدوى أخرى. أخبر طبيبك على الفور في حال التلامس مع أي شخص مصاب بالحصبة، جدري الماء أو الهربس النطاقي في الشهور الثلاثة الماضية.</li><li>إذا كنت تعاني من عدوى الديدان الاستوائية.</li><li>إذا كنت تعاني من عدوى فطرية جهازية.</li></ul><p dir="RTL"><strong>الاحتياطات والتحذيرات</strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي قبل تناول بريدو، خصوص اً إذا كنت تعاني، عانيت مسبقاً أنت أو أحد أفراد عائلتك من:</p><ul dir="rtl"><li>اكتئاب شديد أو مرض هوسي اكتئابي (اضطراب ثنائي القطب). يشمل ذلك الإصابة بالاكتئاب قبل أو في أثناء تناول أدوية الستيرويدات مثل بريدو.</li><li>السل (التدرن)؛</li><li>مرض السكري؛</li><li>الصرع؛</li><li>الاكتئاب أو مرض عقلي آخر؛</li><li>مرض في العين يسببه ارتفاع ضغط العين (الزرق)؛</li><li>ترقق العظام (هشاشة العظام)؛</li><li>مشاكل في العضلات عند تناول الستيرويدات سابقاً؛</li><li>تقرحات في المعدة؛</li><li>فشل كلوي، ارتفاع ضغط الدم، فشل القلب أو التعرض مؤخراً لنوبة قلبية؛</li><li>نوبة التصلّب الجلدي (المعروفة أيضاً بالتصلّب الجهازي، اضطراب المناعة الذاتي) لأن الجرعات اليومية البالغة 15 ملغم أو أكثر قد تزيد من خطر حدوث مضاعفات خطيرة تدعى نوبة التصلّب الجلدي والنوبة الكلويّة. تشمل علامات نوبة التصلّب الجلدي والنوبة الكلويّة، زيادة في ضغط الدم وانخفاض في إنتاج البول. قد ينصح الطبيب بإجراء فحوصات لضغط دمك وللبول بانتظام؛</li><li>أي مشكلات بالكبد؛</li><li>قصور الغدة الدرقية.</li></ul><p dir="RTL">إذا كان ينطبق عليك أي مما سبق، أو إذا لم تكن متأكداً، فتحدث مع طبيبك أو الصيدلي قبل استخدام هذا الدواء.</p><p dir="RTL"><strong>مشاكل الصحة العقلية أثناء تناول بريدنيزولون</strong></p><p dir="RTL">قد تحدث مشاكل الصحة العقلية أثناء تناول الستيرويدات مثل بريدنيزولون (انظر أيضاً القسم 4، &quot;الآثار الجانبية المحتملة&quot;).</p><ul dir="rtl"><li>قد تكون هذه الأمراض شديدة.</li><li>عادةً ما تظهر في غضون أيام أو أسابيع قليلة من بدء تناول العلاج.</li><li>من المرجح حدوثها بشكل أكبر مع الجرعات العالية.</li><li>تختفي معظم هذه المشاكل في حال تقليل الجرعة أو إيقاف الدواء. لكن في حال ظهور مشاكل، فقد تحتاج إلى علاج.</li></ul><p dir="RTL">أخبر الطبيب في حال ظهور أي علامات عليك (أو على شخص يتناول هذا الدواء) تنذر بمشاكل تتعلق بالصحة العقلية. يعد ذلك أمر اً مهماً خصوصاً في حال شعورك بالاكتئاب أو في حال التفكير بالانتحار. حدثت مشاكل تتعلق بالصحة العقلية أيضاً عند القليل من الحالات عندما تم تقليل الجرعات أو إيقاف الدواء تماماً.</p><p dir="RTL">تحدث إلى الطبيب إذا كانت الرؤية غير واضحة، تواجه صعوبة في القراءة أو عند حدوث أي تغيير آخر في الرؤية أثناء أو بعد العلاج.</p><p dir="RTL">ينصح بإجراء فحوصات منتظمة مع الأطباء (بما في ذلك فحوصات الرؤية على فترات زمنية مدتها ثلاثة أشهر) خلال فترة العلاج على المدى الطويل.</p><p dir="RTL"><strong>الأدوية الأخرى وبريدو</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، تناولت مؤخر اً أو قد تتناول أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.</p><p dir="RTL">يعد ذلك أمراً مهماً خاصةً إذا كنت تتناول:</p><ul dir="rtl"><li>أدوية الصرع مثل كاربامازيبين، فينوباربيتون، فينيتوين أو بريميدون؛</li><li>المضادات الحيوية مثل ريفامبيسين، إيريثروميسين؛</li><li>ميفيبريستون (يستخدم لإجهاض الحمل)؛</li><li>ريتونافير (يستخدم لعلاج فيروس العوز المناعي البشري)؛</li><li>وسائل منع الحمل التي تؤخذ عن طريق الفم؛</li><li>سوماتروبين (يستخدم لعلاج مشاكل النمو)؛</li><li>أدوية مرض السكري مثل الأنسولين، جليبانكلاميد أو الميتفورمين؛</li><li>الأدوية المستخدمة لعلاج ارتفاع ضغط الدم، مثل مدرات البول &nbsp;(أقراص الماء) مثل: بيندروفلوميثيازيد وفوروسيميد؛</li><li>وارفارين أو الأدوية الأخرى المستخدمة لترقيق الدم؛</li><li>الأسبرين أو الأدوية المشابهة؛</li><li>ثيوفيلين (يستخدم لعلاج الربو)؛</li><li>الأدوية المستخدمة لعلاج العدوى الفطرية مثل الأمفوتريسين، كيتوكونازول؛</li><li>أسيتازولاميد (يستخدم لعلاج الزرق)؛</li><li>كاربينوكسولون (يستخدم لعلاج تقرحات المعدة)؛</li><li>ميثوتريكسات (يستخدم لالتهاب المفاصل الروماتويدي، الصدفية وأنواع معينة من السرطان)؛</li><li>أي دواء ينتمي إلى مجموعة الأدوية التي تسمى المحاكيات الودية؛</li><li>الأدوية المستخدمة لعلاج الوهن العضلي الوبيل؛</li><li>الأدوية المستخدمة لجعل الأشعة السينية أوضح؛</li><li>سيكلوسبورين (يستخدم لوقف رفض الجسم لزراعة نخاع العظم أو الأعضاء).</li></ul><p dir="RTL">يرجى إخبار طبيبك إذا كنت تتناول أو تناولت مؤخر اً أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.</p><p dir="RTL">قد تزيد بعض الأدوية من تأثير بريدو وقد يرغب طبيبك في مراقبتك بعناية إذا كنت تتناول هذه الأدوية (بما في ذلك بعض الأدوية لفيروس العوز المناعي البشري: ريتونافير، الكوبيكستات).</p><p dir="RTL"><strong>الحمل، الرضاعة والخصوبة</strong></p><p dir="RTL">إسألي طبيبكِ أو الصيدلي للحصول على المشورة قبل تناول هذا الدواء، إذا كنتِ حاملاً أو تقومين بالرضاعة الطبيعية، تعتقدين بأنك حامل أو تخططين لإنجاب طفل.</p><p dir="RTL"><em>الحمل</em></p><p dir="RTL">خلال فترة الحمل، يجب أن يبدأ العلاج فقط بعد إجراء تقييم دقيق للمنافع/المخاطر. نظر اً لأنه لا يمكن استبعاد تأخر النمو والأضرار التي ستلحق بالجنين بعد المعالجة المطوّلة بالستيرويدات القشرية أثناء الحمل، يرجى إبلاغ طبيبك إذا كنتِ تريدين الحمل، كنتِ حامل بالفعل أو إذا كنت تعتقدين بأنك حامل.</p><p dir="RTL"><em>الرضاعة</em></p><p dir="RTL">تعبر الستيرويدات القشرية، مثل بريدنيزولون في حليب الثدي. لم يتم حتى الآن الإبلاغ عن الأضرار التي ستلحق بالرضيع. مع ذلك، عند إعطاء جرعات عالية من بريدنيزولون، يجب عليكِ تجنب الرضاعة الطبيعية لمدة 4 ساعات بعد الجرعة. يرجى استشارة طبيبكِ .</p><p dir="RTL"><em>الخصوبة</em></p><p dir="RTL">تم ملاحظة اضطرابات عكسية في تكوين الحيوانات المنوية بعد جرعات عالية من بريدنيزولون ( 30 ملغم/يوم لمدة 4 أسابيع على الأقل)، والتي استمرت لعدة أشهر بعد التوقف عن تناول الدواء.</p><p dir="RTL"><strong>تأثير بريدو على القيادة واستخدام الآلات</strong></p><p dir="RTL">ينبغي ألا يؤثر هذا الدواء على قدرتك على القيادة أو استخدام الآلات.</p><p dir="RTL"><strong>يحتوي بريدو على ميثيل بارا- هيدروكسي البنزوات (ميثيل بارابين)، بروبيلين جليكول وسكر</strong></p><p dir="RTL"><em>يحتوي بريدو على ميثيل بارا- هيدروكسي البنزوات (ميثيل بارابين)</em></p><ul dir="rtl"><li>قد يسبب ردود فعل تحسسية (من المحتمل أن تكون متأخرة).</li></ul><p><em>يحتوي بريدو على بروبيلين جليكول</em></p><ul dir="rtl"><li>إذا كان عمر طفلك أقل من 5 سنوات، تحدث إلى طبيبك أو الصيدلي &nbsp;قبل إعطائه هذا الدواء، خاصة إذا كان يستخدم أدوية أخرى تحتوي على بروبيلين جليكول أو كحول.</li></ul><p><em>يحتوي بريدو على سكر</em></p><ul><li>ينبغي أن يؤخذ ذلك في الاعتبار عند مرضى السكري. إذا أخبرك &nbsp;طبيبك بأن لديك حساسية تجاه بعض السكريات، اتصل بطبيبك قبل تناول هذا المستحضر الطبي.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p dir="RTL">قم دائماً بتناول هذا الدواء تماماً كما وصفه لك طبيبك. تحقق من طبيبك أو الصيدلي إذا لم تكن متأكداً.</p><ul dir="rtl"><li>من الأفضل تناول الشراب دون تخفيف.</li><li>يجب تناول الشراب عن طريق الفم.</li><li>يفضل تناول الشراب كجرعة واحدة في الصباح. مع ذلك، يمكن الاعتماد على جرعة يومية مقسمة إذا لزم الأمر.</li><li>لدى الأطفال، يفضل تناول الدواء كجرعة واحدة على أيام متناوبة.</li><li>قم برجّ الشراب جيّد اً قبل الاستخدام.</li><li>إذا كنت تخضع لعلاج على مدى طويل، فتأكد من عدم نفاد كمية الشراب لديك.</li><li>تعتمد الجرعة على الحالة التي تتم معالجتها، وللبالغين، يمكن أن تتراوح بشكل كبير بين 10 ملغم و 30 ملغم يومياً مقسمة على جرعات. سيعطيك طبيبك أقل جرعة تناسب حالتك.</li><li>تحتوي العبوة على حقنة للاستخدام الفموي لقياس الجرعة بحجم 5 مللتر.</li></ul><p dir="RTL"><strong>الاستخدام لدى الأطفال</strong></p><p dir="RTL">لعلاج نوبات الربو الحادة، قد يصف طبيب طفلك ما يلي:</p><ul dir="rtl"><li>للأطفال الذين تقل أعمارهم عن سنتين، 10 ملغم يومياً، حتى ثلاثة أيام؛</li><li>بالنسبة للأطفال من عمر سنتين حتى 5 سنوات، 20 ملغم يومياً. العلاج لمدة تصل إلى 3 أيام عادة ما يكون كافياً، ولكن سيتم تحديد مدة العلاج من قبل طبيبك، وفقاً لعدد الأيام اللازمة للتعافي.</li><li>بالنسبة للأطفال الذين تزيد أعمارهم عن 5 سنوات، 30 ملغم أو أكثر يومياً (حتى 40 ملغم يومياً). في حال تم وصف أكثر من 30 ملغم يومياً، اسأل طبيب طفلك، لأنه قد يكون شكل جرعة مختلفة من بريدنيزولون أكثر ملاءمة.</li></ul><p>إذا شعرت أن هذا الدواء له تأثير قوي جداً أو ضعيف جد اً، فتحدث مع طبيبك أو الصيدلي.</p><p dir="RTL"><strong>إذا تناولت جرعة زائدة من بريدو</strong></p><p dir="RTL">إذا تناولت جرعة زائدة من بريدو عما تم وصفه لك، فاتصل بطبيبك أو قسم الطوارئ في أقرب مستشفى منك على الفور. اصطحب هذه النشرة و/أو العبوة معك لتبين لطبيبك ما تناولته.</p><p dir="RTL"><strong>إذا نسيت تناول بريدو</strong></p><p dir="RTL">إذا نسيت تناول بريدو، تناول الجرعة التالية بمجرد أن تتذكر ذلك ما لم يكن وقت الجرعة التالية قد اقترب. لا تقم بتناول جرعة مضاعفة للتعويض عن الجرعة المنسية.</p><p dir="RTL"><strong>إذا توقفت عن تناول بريدو</strong></p><p dir="RTL">تحدث مع طبيبك إذا كنت ترغب في التوقف عن تناول هذا الشراب &ndash; فقد يرغب طبيبك في تقليل جرعتك تدريجياً.</p><p dir="RTL">لا تتوقف عن تناول هذا الشراب ما لم يخبرك طبيبك بذلك، حتى إذا شعرت بتحسن، حيث إن ذلك قد يجعلك تشعر بأنك لست في صحة جيدة. إذا توقفت عن تناول الشراب فجأة، فقد يتسبب ذلك في حدوث أعراض انسحابية مثل الحمّى، المرض، ألم في العضلات وفي المفاصل، سيلان الأنف، تقرح، احمرار ودبق العينين (التهاب الملتحمة)، حكة في الجلد وفقدان الوزن.</p><p>إذا كان لديك أي أسئلة إضافية حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثاراً جانبية، إلا أنه ليس بالضرورة أن تحدث لدى جميع مستخدمي هذا الدواء.</p><p dir="RTL">يمكن أن تتسبب الستيرويدات بما في ذلك بريدنيزولون في حدوث مشاكل شديدة تتعلق بالصحة العقلية، مثل تلك المدرجة أدناه. هي شائعة الحدوث في كل من البالغين والأطفال. إذا لاحظت ظهور أي من هذه المشكلات،</p><p dir="RTL">تحدث إلى طبيبك فوراً:</p><ul dir="rtl"><li>الشعور بالاكتئاب، بما في ذلك التفكير في الانتحار.</li><li>الشعور بالابتهاج (الهوس) أو شعورك بحالات مزاجية متقلبة.</li><li>الشعور بالقلق، وجود مشاكل في النوم، مواجهة صعوبة في التفكير أو شعورك بالارتباك وفقدان الذاكرة.</li><li>الشعور، سماع أو رؤية أشياء غير موجودة (الهلاوس). لديك أفكار غريبة ومرعبة، تتسبب في تغييرات في تصرفاتك أو الشعور بالوحدة.</li></ul><p dir="RTL"><strong>يمكن أن تكون الآثار الجانبية التالية بمثابة علامات على رد فعل تحسسي. إذا لاحظت أي اً مما يلي، فتوقف عن تناول بريدو وأخبر طبيبك فور اً</strong><strong>:</strong></p><ul dir="rtl"><li>حكة أو طفح جلدي؛</li><li>تورم الوجه، الشفتين أو الحلق؛</li><li>صعوبة في التنفس أو الصفير.</li></ul><p dir="RTL"><strong>يمكن أن تحدث الآثار الجانبية التالية في حال تناول الستيرويدات</strong></p><p dir="RTL"><strong>بجرعات كبيرة لفترة طويلة</strong><strong>:</strong></p><ul dir="rtl"><li>الشعور العام بالتوعك؛</li><li>الغثيان؛</li><li>الفواق؛</li><li>عسر الهضم أو شعور بانزعاج بالمعدة؛</li><li>قرحة المعدة (حيث يمكن أن تتسبب في فتق ونزيف) أو قرحة في المريء؛</li><li>السلاق؛</li><li>التهاب البنكرياس مما يتسبب في وجود ألم بالبطن (التهاب البنكرياس)؛</li><li>ضعف في العضلات؛</li><li>ألم في العضلات؛</li><li>ترقق العظام والذي يزيد من احتمالية حدوث الكسور (هشاشة العظام)؛</li><li>تلف بالأوتار؛</li><li>تيبس المفصل مما يتسبب في تقييد الحركة، ألم وتشنجات عضلية؛</li><li>احتباس السوائل مما يتسبب في وجود تورم؛</li><li>الشعور بالجفاف؛</li><li>ارتفاع ضغط الدم (فرط ضغط الدم)؛</li><li>التئام الجروح ببطء، ترقق الجلد، التكدم، حب الشباب، العلامات التي تشبه علامات التمدد؛</li><li>بقع صغيرة حمراء، أرجوانية أو زرقاء توجد على سطح الجلد (تسببها الأوعية الدموية تحت الجلد)؛</li><li>قصور في وظائف الغدة الكظرية؛</li><li>تباطؤ نمو الرضع، الأطفال والمراهقين؛</li><li>عدم انتظام أو توقف الدورة الشهرية؛</li><li>وجه متورم مستدير (وجه كوشينغ أو وجه بدري)؛</li><li>فرط نمو الشعر؛</li><li>ازدياد الشهية للطعام وزيادة الوزن؛</li><li>عدم تحمل الكربوهيدرات؛</li><li>تقلبات في الحالة المزاجية، الإدمان، الاكتئاب، صعوبة في النوم، تفاقم الفصام؛</li><li>صداع شديد يصاحبه عدم وضوح في الرؤية أو مشاكل مؤقتة في الرؤية لدى الأطفال (عادة بعد إيقاف العلاج)؛</li><li>تفاقم حالات الصرع؛</li><li>ارتفاع الضغط في العينين (الزرق)، كاتاراكت، ترقق والتهاب القرنية (جزء من العين)، تفاقم أمراض العيون الفيروسية أو الفطرية، عدم وضوح في الرؤية ومشاكل بصرية، اضطرابات المشيمية والشبكية (اعتلال المشيمية والشبكية)؛</li><li>نوبة قلبية (آلام شديدة مفاجئة بالصدر)؛</li><li>تغيرات في كيمياء الجسم؛</li><li>زيادة في عدد كرات الدم البيضاء؛</li><li>تكوّن جلطات دموية؛</li><li>البُرفيريّة؛</li><li>متلازمة ستيفنز- جونسون؛</li><li>قد يؤدي استخدام جرعات كبيرة ولفترة طويلة من الستيرويدات إلى ضعف الجهاز المناعي، والذي يمكن أن يزيد من خطر تدهور حالتك (الخباثة).&nbsp; &nbsp; &nbsp;&nbsp;</li></ul><p dir="RTL">نوبة التصلّب الجلدي والنوبة الكلويّة لدى المرضى الذين يعانون بالفعل من تصلب جلدي (اضطراب المناعة الذاتي). تشمل علامات نوبة التصلّب الجلدي والنوبة الكلويّة، زيادة في ضغط الدم وانخفاض في إنتاج البول.</p><p dir="RTL">لقد تم الإبلاغ عن حدوث ساركومة كابوزي (نوع من أنواع السرطان) لدى المرضى الذين يتناولون الستيرويدات القشرية. مع ذلك، قد يختفي هذا بمجرد توقف العلاج.</p><p dir="RTL">يمكن أن يسهل هذا الدواء من إصابتك بحالات عدوى نادراً جدا&nbsp;ما تكون مميتة. يمكن أن تتدهور حالات العدوى مثل جدري الماء والحصبة أو قد تتكرر الإصابة بالسل (التدرن).</p><p>إذا كنت تعاني من أي آثار جانبية، فتحدث إلى طبيبك، الصيدلي أو الممرض. يتضمن ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.<br />يحفظ عند درجة حرارة أقل من 30 &deg; مئوية.<br />يحفظ داخل العبوة الأصلية.<br />مدة الصلاحية بعد الفتح لأول مرة هي شهر واحد.<br />لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية. يشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر.<br />لا تستخدم هذا الدواء إذا لاحظت أي علامات تلف واضحة عليه.<br />لا تتخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. اتبع هذه الإجراءات للحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي بريدنيزولون فوسفات الصوديوم.</p><p dir="RTL">يحتوي كل 1 مللتر من بريدو 15 ملغم/ 5 مللتر شراب على بريدنيزولون فوسفات الصوديوم يكافئ 3 ملغم بريدنيزولون.</p><p>المواد الأخرى المستخدمة في التركيبة التصنيعية هي ميثيل بارابين، بروبيلين جليكول، جليسيرين، فوسفات الصوديوم ثنائي القاعدة، فوسفات الصوديوم أحادي القاعدة، إيديتا ثنائي الصوديوم، سكارين الصوديوم،&nbsp;نكهة كريم كراميل السائلة، نكهة التوت السائلة، سكر ،&nbsp;&nbsp;FD&amp;C رقم 40 وماء منقّى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">بريدو 15 ملغم/ 5 مللتر شراب هو شراب سائل نقي وذو لون أحمر بنكهة التوت.</p><p dir="RTL">بريدو 15 ملغم/ 5 مللتر شراب متوفر في قنينة زجاجية كهرمانية محكمة الإغلاق بغطاء ذو لون أبيض مقاوم لعبث الأطفال. تحتوي العبوة أيضاً على حقنة للاستخدام الفموي لقياس الجرعة حجمها 5 مللتر.</p><p dir="RTL">حجم العبوة: قنينة واحدة ( 120 مللتر).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اسم وعنوان مالك رخصة التسويق </strong></p><p dir="RTL">شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية</p><p dir="RTL">هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: jpimedical@hikma.com</p><p dir="RTL"><strong>الشركة المصنعة</strong></p><p dir="RTL">شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية</p><p dir="RTL">هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: jpimedical@hikma.com</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             تمت مراجعة هذه النشرة بتاريخ 08 /2019 ؛ رقم النسخة SA 1.0.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Predo 15 mg/5 ml Syrup
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 1 ml contains prednisolone sodium phosphate equivalent to 3 mg prednisolone.
Excipients with known effect:
Methyl p‐hydroxybenzoate (methyl paraben), propylene glycol and sugar.
For a full list of excipients, see section 6.1 List of Excipients.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Syrup.
Red clear liquid syrup with raspberry flavour.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><ul><li>Rheumatological disorders and connective tissue diseases such as:</li></ul><p>_ Rheumatoid arthritis (for primary chronic disease and maintenance therapy)<br />_ Systemic lupus erythematosus (non‐organ threatening disease)<br />_ Mild‐moderate juvenile dermatomyositis</p><ul><li>Severe or debilitating allergic conditions, not treatable in a conventional manner such as:</li></ul><p>_ Bronchial asthma in children<br />_ Bronchial asthma in adults (for maintenance therapy)</p><ul><li>Sarcoidosis in children and for maintenance therapy in adults</li><li>Acquired haemolytic anaemia (autoimmune, for maintenance therapy)</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Posology</em></strong></p><p>The lowest dosage that will produce an acceptable result should be used (See section 4.4 Special warnings and precautions for use); when it is possible to reduce the dosage, this must be accomplished by stages. During prolonged therapy any intercurrent illness, trauma or surgical procedure will require a temporary increase in dosage; if corticosteroids have been stopped following prolonged therapy they may need to be temporarily re‐introduced.</p><p>The medicinal product should preferably be taken as a single dose in the morning. However, divided daily dosages may be employed if required.</p><p><strong>Adults:</strong></p><p>The dose used will depend upon the disease, its severity, and the clinical response obtained. The following regimens are for guidance only. Divided dosage is usually employed.</p><p><strong>Short‐term treatment:</strong></p><p>20 to 30 mg daily for the first few days, subsequently reducing the daily dosage by 2.5 or 5 mg every two to five days, depending upon the response.</p><p><strong>Rheumatoid arthritis:</strong></p><p>7.5 to 10 mg daily. For maintenance therapy the lowest effective dosage is used.</p><p><strong>Most other indicated conditions:</strong></p><p>Indications for Predo have been restricted to those where a large proportion of patients and a large proportion of doses (maintenance phase) in a particular patient will be 30 mg or below.</p><p>10 to 30 mg of prednisolone should be taken daily for one to three weeks, then reducing to the minimum effective dosage.</p><p>For the administration of higher doses in particular haematological forms, dermatologic forms, etc., the use of a more appropriate prednisolone presentation is recommended.</p><p><strong>Children:</strong></p><p>Fractions of the adult dosage may be used (e.g. 75% at 12 years, 50% at 7 years and 25% at 1 year) but clinical factors must be given due weight.</p><p><u>For treatment of bronchial asthma:</u></p><p><em>Children under 2 years</em>: up to 10 mg daily.</p><p><em>Children 2‐5 years inclusive</em>: up to 20 mg daily.</p><p><em>Children older than 5 years</em>: 30 mg daily or more (up to 40 mg daily) may be used. If the doctor prescribe more than 30 mg daily, a more appropriate prednisolone presentation should be used.</p><p>Corticosteroids cause growth retardation in infancy, childhood and adolescence which may be irreversible. Treatment should be limited to the minimum dosage for the shortest possible time. In order to minimise suppression of the hypothalamo‐pituitary adrenal axis and growth retardation, treatment should be administered where possible as a single dose on alternate days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Tuberculosis, peptic ulcer, psychosis, ocular herpes simplex. Tropical worm infections, systemic  infections including fungal infections, unless specific anti‐infective therapy is employed. Live  virus immunization.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adrenal cortical atrophy develops during prolonged therapy and may persist for years after stopping treatment. Withdrawal of corticosteroids after prolonged therapy must therefore always be gradual to avoid acute adrenal insufficiency, being tapered off over weeks or months according to the dose and duration of treatment.</p><p>Suppression of the HPA axis and other undesirable effects may be minimised by using the lowest effective dose for the minimum period, and by administering the daily requirement as a single morning dose or whenever possible as a single morning dose on alternate days. Frequent patient review is required to appropriately titrate the dose against disease activity. (See section 4.2 Posology and method of administration).</p><p>Suppression of the inflammatory response and immune function increases the susceptibility to infections and their severity. The clinical presentation may often be atypical and serious infections such as septicaemia and tuberculosis may be masked and may reach an advanced stage before being recognised.</p><p>Chickenpox is of particular concern since this normally minor illness may be fatal in immunosuppressed patients. Patients without a definite history of chickenpox should be advised to avoid close personal contact with chickenpox or herpes zoster and if exposed they should seek urgent medical attention. If the patient is a child parents must be given the above advice. Passive immunisation with varicella zoster immunoglobulin (VZIG) is needed by exposed non‐immune patients who are receiving systemic corticosteroids or who have used them within the previous 3 months; this should be given within 10 days of exposure to chickenpox. If a diagnosis of chickenpox is confirmed, the illness warrants specialist care and urgent treatment.</p><p>Corticosteroids should not be stopped and the dose may need to be increased.</p><p>Patients should be advised to take particular care to avoid exposure to measles and to seek immediate advice if exposure occurs. Prophylaxis with intramuscular normal immunoglobulin may be needed.</p><p>Live vaccines should not be given to individuals with impaired immune responsiveness caused by high doses of corticosteroids. The antibody response to other vaccines may be diminished.</p><p>Kaposi&#39;s sarcoma has been reported to occur in patients receiving corticosteroid therapy. Discontinuation of corticosteroids may result in clinical remission.</p><p>Because of the possibility of fluid retention, care must be taken when corticosteroids are administered to patients with renal insufficiency or hypertension or congestive heart failure.</p><p>Corticosteroids may worsen diabetes mellitus, osteoporosis, hypertension, glaucoma and epilepsy and therefore patients with these conditions or a family history of them should be monitored frequently.</p><p>Care is required and frequent patient monitoring necessary where there is a history of severe affective disorders (especially a previous history of steroid psychosis), previous steroid myopathy, peptic ulceration, hypothyroidism, recent myocardial infarction or patients with a history of tuberculosis.</p><p>In patients with liver failure, blood levels of corticosteroid may be increased, as with other drugs which are metabolised in the liver. Frequent patient monitoring is therefore necessary.</p><p>Physicians should be aware that corticoids have been reported to precipitate porphyria. As well, one case of a reversible Steven‐Johnson‐Syndrome (SJS) was reported in connection with prednisolone treatment.</p><p><strong>Visual disturbance</strong></p><p>Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision, or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.</p><p>Chorioretinopathy may result in impaired vision, including loss of vision.</p><p>Regular checkups with doctors (including vision checkups in three month‐intervals) are advised during long term treatment.</p><p>At high doses, sufficient calcium intake and sodium restriction, as well as potassium levels should be monitored.</p><p><strong>Scleroderma renal crisis</strong></p><p>Caution is required in patients with systemic sclerosis because of an increased incidence of (possibly fatal) scleroderma renal crisis with hypertension and decreased urinary output observe with a daily dose of 15 mg or more prednisolone. Blood pressure and renal function (s‐creatinine) should therefore be routinely checked. When renal crisis is suspected, blood pressure should be carefully controlled.</p><p><em>Use in Children: </em>Corticosteroids cause dose‐related growth retardation in infancy, childhood and adolescence, which may be irreversible.</p><p><em>Use in the Elderly: </em>The common adverse effects of systemic corticosteroids may be associated with more serious consequences in old age, especially osteoporosis, hypertension, hypokalaemia, diabetes, susceptibility to infection and thinning of the skin. Close clinical supervision is required to avoid life‐threatening reactions.</p><p>Patients/and or caregivers should be warned that potentially severe psychiatric adverse reactions may occur with systemic steroids (see section 4.8 Undesirable Effects). Symptoms typically emerge within a few days or weeks of starting the treatment. Risks may be higher with high doses/systemic exposure (see also section 4.5 Interaction with other medicinal products and other forms of interaction), although dose levels do not allow prediction of the onset, type, severity or duration of reactions. Most adverse reactions resolve after either dose reduction or withdrawal of the medicine, although specific treatment may be necessary. Patients/caregivers should be encouraged to seek medical advice if worrying psychological symptoms develop, especially if depressed mood or suicidal ideation is suspected. Patients/caregivers should also be alert to possible psychiatric disturbances that may occur either during or immediately after dose tapering/withdrawal of systemic steroids, although such reactions have been reported infrequently.</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with existing or a previous history of severe affective disorders in themselves or in their first‐degree relatives. These would include depressive or manic‐depressive illness and previous steroid psychosis.</p><p><strong>Withdrawal</strong></p><p>In patients who have received more than physiological doses of systemic corticosteroids (approximately 7.5 mg prednisolone or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced. Clinical assessment of disease activity may be needed during withdrawal. If the disease is unlikely to relapse on withdrawal of systemic corticosteroids but there is uncertainty about HPA suppression, the dose of systemic corticosteroid may be reduced rapidly to physiological doses. Once a daily dose equivalent to 7.5mg of prednisolone is reached, dose reduction should be slower to allow the HPA‐axis to recover.</p><p>Abrupt withdrawal of systemic corticosteroid treatment, which has continued up to 3 weeks is appropriate if it is considered that the disease is unlikely to relapse. Abrupt withdrawal of doses of up to 40mg daily of prednisolone, or equivalent for 3 weeks is unlikely to lead to clinically relevant HPA‐axis suppression, in the majority of patients. In the following patient groups, gradual withdrawal of systemic corticosteroid therapy should be considered even after courses lasting 3 weeks or less:</p><ul><li>Patients who have had repeated courses of systemic corticosteroids, particularly if taken for greater than 3 weeks,</li><li>When a short course has been prescribed within one year of cessation of long‐term therapy (months or years),</li><li>Patients who may have reasons for adrenocortical insufficiency other than exogenous corticosteroid therapy,</li><li>Patients receiving doses of systemic corticosteroid greater than 40mg daily of prednisolone,</li><li>Patients repeatedly taking doses in the evening.</li></ul><p>During prolonged therapy any intercurrent illness, trauma or surgical procedure will require a temporary increase in dosage; if corticosteroids have been stopped following prolonged therapy they may need to be temporarily reintroduced.</p><p><strong>Predo contains methyl p‐hydroxybenzoate (methyl paraben), propylene glycol and sugar</strong></p><p><em>Predo contains methyl p‐hydroxybenzoate (methyl paraben)</em></p><ul><li>May cause allergic reactions (possibly delayed).</li></ul><p><em>Predo contains propylene glycol</em></p><ul><li>If your child is less than 5 years old, talk to your doctor or pharmacist before giving them this medicine, in particular if they use other medicines that contain propylene glycol or alcohol.</li></ul><p><em>Predo contains sugar</em></p><ul><li>This should be taken into account in patients with diabetes mellitus. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone, ephedrine and aminoglutethimide enhance the metabolism of corticosteroids and its therapeutic effects may be reduced. Therefore it may be necessary to adjust the dose accordingly.</p><p>Mifepristone may reduce the effect of corticosteroids for 3‐4 days.</p><p>Erythromycin and ketoconazole may inhibit the metabolism of some corticosteroids.</p><p>Ciclosporin increases plasma concentration of prednisolone. The same effect is possible with ritonavir.</p><p>Oestrogens and other oral contraceptives may potentiate the effects of glucocorticoids and dosage adjustments may be required if oral contraceptives are added to or withdrawn from a stable dosage regimen.</p><p>The desired effects of hypoglycaemic agents (including insulin), anti‐hypertensives and diuretics are antagonised by corticosteroids.</p><p>The growth promoting effect of somatotropin may be inhibited by the concomitant use of corticosteroids.</p><p>Steroids may reduce the effects of anticholinesterases in myasthenia gravis and cholecystographic x‐ray media.</p><p>The efficacy of coumarin anticoagulants and warfarin may be enhanced by concurrent corticosteroid therapy and close monitoring of the INR or prothrombin time is required to avoid spontaneous bleeding.</p><p>Concomitant use of aspirin and Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) with corticosteroids increases the risk of gastro‐intestinal bleeding and ulceration.</p><p>The renal clearance of salicylates is increased by corticosteroids and steroid withdrawal may result in salicylate intoxication.</p><p>The hypokalaemic effects of acetazolamide, loop diuretics, thiazide diuretics, and carbenoxolone, are enhanced by corticosteroids. The risk of hypokalaemia is increased with theophylline and amphotericin. Corticosteroids should not be given concomitantly with amphotericin, unless required to control reactions.</p><p>The risk of hypokalaemia also increases if high doses of corticosteroids are given with high doses of bambuterol, fenoterol, formoterol, ritodrine, salbutamol, salmeterol and terbutaline. The toxicity of cardiac glycosides is increased if hypokalaemia occurs with corticosteroids.</p><p>Concomitant use with methotrexate may increase the risk of haematological toxicity.</p><p>High doses of corticosteroids impair the immune response and so live vaccines should be avoided (see section 4.4 Special warnings and precautions for use).</p><p>In rare cases the concomitant treatment with corticosteroids and fluoroquinolones may increase the risk of tendon rupture.</p><p>Co‐treatment with CYP3A inhibitors, including cobicistat‐containing products, is expected to increase the risk of systemic side‐effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side‐effects, in which case patients should be monitored for systemic corticosteroid side‐effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p><u>US FDA Pegnancy category: C/D.</u></p><p>The ability of glucocorticoids to cross placenta varies between individual drugs, however, 88% of prednisolone is inactivated as it crosses the placenta.</p><p>Animal studies indicate that administration of pharmacological doses of glucocorticoids during pregnancy may increase the fetus risk of intrauterine growth retardation, adult cardiovascular and/or metabolic disease and may have an effect on the glucocorticoid receptor density, and neurotransmitter turnover or neurobehavioural development.</p><p>Glucocorticoids caused cleft palate formation in animal experiments. There is an ongoing discussion on the possibility of an increased risk of oral cleft formation in the human fetus as a result of the administration of glucocorticoids during the first trimester.</p><p>If glucocorticoids are administered towards the end of pregnancy, there is a risk of atrophy of the fetal adrenal cortex, which may necessitate replacement therapy in the newborn, which has to be slowly reduced.</p><p>During pregnancy, Predo should only be prescribed when the benefits to the mother and child outweigh the risks. The lowest effective dose of Predo needed to maintain adequate disease control should be used. Patients with pre‐eclampsia or fluid retention require close monitoring.</p><p><strong>Breastfeeding</strong></p><p>Glucocorticoids are excreted in small amounts in breast milk (up to 0.23% of an individual dose). However, doses of up to 40mg daily of prednisolone are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breast feeding are likely to outweigh any theoretical risk.</p><p>The milk/plasma concentration ratio increases with increasing doses (e.g. 25 % of the serum concentration are found in the breast milk with 80 mg prednisolone daily). Therefore, when high doses of prednisolone are given, it is recommended to avoid breastfeeding for 4 h after a dose.</p><p><strong>Fertility</strong></p><p>After high prednisolone doses (30 mg/day for at least 4 weeks) reversible disturbances of spermatogenesis has been observed, which lasted for several months after stop taking the medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Data reported under this section originate from post authorization and spontaneous reporting, therefore estimation of frequency of adverse reaction could not be established.</p><p>The incidence of predictable undesirable effects, including hypothalamo‐pituitary‐adrenal (HPA) suppression, correlates with the relative potency of the drug, dosage, timing of administration and the duration of treatment (see section 4.4 Special warnings and precautions for use).</p><p>The following side effects may be associated with the long‐term systemic use of corticosteroids.</p><p><strong>Infections and Infestations</strong></p><p>Infection susceptibility increased, opportunistic infection, latent tuberculosis (see section 4.4 Special warnings and precautions for use).</p><p><strong>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</strong></p><p>Kaposi&#39;s sarcoma (see section 4.4 Special warnings and precautions for use).</p><p><strong>Blood and lymphatic system disorders</strong></p><p>Leukocytosis.</p><p><strong>Immune system disorders</strong></p><p>Hypersensitivity, anaphylactic reaction.</p><p><strong>Endocrine disorders</strong></p><p>Suppression of the HPA axis.</p><p>Cushingoid.</p><p>Carbohydrate intolerance, diabetes mellitus exacerbated.</p><p><strong>Metabolism and nutrition disorders</strong></p><p>Sodium retention, fluid retention, hypokalaemia, hypokalaemic alkalosis, increased appetite, electrolyte imbalance, protein total abnormal</p><p><strong>Psychiatric disorders</strong></p><p>Dependence.</p><p>Affective disorder: irritability, euphoric mood, depressed mood, affect lability, suicidal ideation.</p><p>Psychotic disorder: mania, delusions, hallucinations, schizophrenia aggravated.</p><p>Abnormal behavior, anxiety, sleep disorder.</p><p>Cognitive disorder: confusion, amnesia.</p><p>A wide range of psychiatric reactions including the above mentioned reactions, are common and may occur in both adults and children. In adults, the frequency of severe reactions has been estimated to be 5‐6%. Psychological effects have been reported on withdrawal of corticosteroids; the frequency is unknown.</p><p><strong>Nervous system disorders</strong></p><p>Dizziness, headache, epilepsy aggravated.</p><p>Intracranial pressure increased, papilloedema, epilepsy.</p><p><strong>Eye disorders</strong></p><p>Glaucoma, papilloedema, posterior subcapsular cataract, chorioretinopathy, vision, blurred (see also section 4.4 Special warnings and precautions for use), exophthalmos, corneal thinning, scleral thinning, eye infection viral, eye infection fungal.</p><p><strong>Ear and labyrinth disorders</strong></p><p>Vertigo.</p><p><strong>Cardiac disorders</strong></p><p>Myocardial rupture (post infarct), cardiac failure congestive.</p><p><strong>Vascular disorders</strong></p><p>Hypertension, embolism.</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p><p>Hiccups.</p><p><strong>Gastrointestinal disorders</strong></p><p>Dyspepsia, nausea, vomiting, abdominal distension, abdominal pain, diarrhoea, oesophageal ulcer, candidiasis, pancreatitis acute.</p><p>Peptic ulcer haemorrhage, peptic ulcer perforation.</p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p>Skin atrophy, skin striae, acne, telangiectasia, hyperhidrosis, rash, pruritus, urticaria, hirsutism, Stevens‐Johnson syndrome.</p><p><strong>Musculoskeletal and connective tissue disorders</strong></p><p>Myopathy, osteoporosis, multiple spinal fractures, osteonecrosis, myalgia.</p><p><strong>Renal and urinary disorders</strong></p><p>Scleroderma renal crisis.</p><p>Amongst the different subpopulations the occurrence of scleroderma renal crisis varies. The highest risk has been reported in patients with diffuse systemic sclerosis. The lowest risk has been reported in patients with limited systemic sclerosis (2%) and juvenile onset systemic sclerosis (1%).</p><p><strong>Reproductive system and breast disorders</strong></p><p>Menstruation irregular, amenorrhoea.</p><p><strong>Congenital, familial and genetic disorders</strong></p><p>Porphyria</p><p><strong>General disorders and administration site conditions</strong></p><p>Impaired healing, malaise.</p><p><strong>Investigations</strong></p><p>Weight increased, intraocular pressure increased.</p><p><strong>Injury, poisoning and procedural complications</strong></p><p>Tendon rupture, contusion.</p><p><strong>Withdrawal Symptoms</strong></p><p>Too rapid a reduction of corticosteroid dosage following prolonged treatment can lead to acute adrenal insufficiency, hypotension and death (See section 4.4 Special warnings and precautions for use).</p><p>A &#39;withdrawal syndrome&#39; may also occur including fever, myalgia, arthralgia, rhinitis, conjunctivitis, painful itchy skin nodules and loss of weight.</p><p>In some instances, withdrawal symptoms may involve or resemble a clinical relapse of the disease for which the patient has been undergoing treatment.</p><p>Other effects that may occur during withdrawal or change of corticosteroid therapy include benign intracranial hypertension with headache and vomiting and papilloedema caused by cerebral oedema.</p><p>Latent rhinitis or eczema may be unmasked.</p><p><strong>Pediatric population</strong></p><p>The following side effects have been reported in the pediatric population.</p><p>Growth retardation in infancy, childhood and adolescence.</p><p>Intracranial pressure increased with papilloedema (pseudo tumour cerebri) after treatment withdrawal.</p><p>For psychiatric reactions in children, refer to the paragraph &ldquo;Psychiatric disorders&rdquo;.</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Center (NPC)</p><p>Fax: + (966‐11) 2057662</p><p>Call NPC at: + (966‐11) 2038222, Exts: 2317‐2356‐2340.</p><p>SFDA Call Center: 19999</p><p>e‐mail: <u>npc.drug@sfda.gov.sa</u></p><p>Website: <u>https://ade.sfda.gov.sa/</u></p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment is unlikely to be needed in cases of acute overdosage.</p><p>Should alterations of the electrolytic balance occur within prolonged therapy at high doses, it would be appropriate to adjust the intake of sodium and potassium. Corticosteroids increase the urinary excretion of calcium.</p><p>In case of overdose, the clinical control of patient&#39;s vital functions, jointly with the common measures for elimination of the non‐absorbed drug (gastric lavage, vegetal charcoal etc), are recommended.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: glucocorticoids, ATC code: H02AB06</p><p>Predo contains prednisolone in the form of the 21‐disodium phosphate ester. Prednisolone sodium phosphate is a synthetic glucocorticoid with the same general properties as prednisolone itself and other compounds classified as corticosteroids. Prednisolone is four times as active as hydrocortisone on a weight for weight basis.</p><p>Prednisolone sodium phosphate is very soluble in water, and is therefore less likely to cause local gastric irritation than prednisolone alcohol, which is only slightly soluble. This is important when high dosages are required, as in immunosuppressive therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Prednisolone is readily absorbed from the gastrointestinal tract with peak plasma concentrations achieved by 1‐2 hours after an oral dose. Plasma prednisolone is mainly protein bound (70‐90%), with binding to albumin and corticosteroid‐binding globulin. The plasma half‐life of prednisolone, after a single dose, is between 2.5‐3.5 hours.</p><p><strong>Distribution</strong></p><p>The volume of distribution and clearance of total and unbound prednisolone are concentration dependent, and this has been attributed to saturable protein binding over the therapeutic plasma concentration range.</p><p><strong>Metabolism</strong></p><p>Prednisolone is extensively metabolised, mainly in the liver, but the metabolic pathways are not clearly defined.</p><p><strong>Excretion</strong></p><p>Over 90% of the prednisolone dose is excreted in the urine, with 7‐30% as free prednisolone, and the remainder being recovered as a variety of metabolites.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no preclinical safety data that could be of relevance to the prescriber that are not already included in other sections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><br />- Methyl paraben<br />- Propylene glycol<br />- Glycerin<br />- Dibasic sodium phosphate<br />- Monobasic sodium phosphate<br />- Disodium edeta<br />- Saccharine sodium<br />- Caramel cream liquid flavour<br />- Raspberry liquid flavour<br />- Sugar<br />- FD&amp;C Red #40<br />- Purified water.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.<br />Store in the original package.<br />The shelf life after first opening is 1 month.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><br />Amber glass bottle sealed with white child resistant cap.</p><p>The pack also contains 5 ml oral dosing syringe.<br />Pack size: 1 bottle (120 ml).<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al‐Kharj Road
P.O. BOX 106229
Riyadh 11666, Saudi Arabia
Tel: + (966‐11) 8107023, + (966‐11) 2142472
Fax: + (966‐11) 2078170
e‐mail: jpimedical@hikma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                18 August 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>